Notice Information
Notice Title
(NU/1433-30) CAF1 - A robust, easily engineered polymer with applications in synthetic biology: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation
Notice Description
Caf1 is secreted from the bacterium Yersinia pestis to protect it from white blood cells during infection. It is formed from 15 kDa monomers that produce robust, flexible polymers up to 2 um in length. We aim to create a spinout company that will initially produce Caf1 polymers and coated plasticware/microcarriers for the 2D cell culture market, predominantly focussed on laboratory research, expanding into commercial companies looking to scale up cell production. The Newcastle-based company will supply these products directly to customers, and through marketing partners who have established distribution networks. We are looking for a CEO/COO/Chairperson to work alongside Daniel Peters to develop a business plan that has considered the best market strategy for Caf1 in preparation for spinout formation and achieving the necessary fundraising The initial brief of the executive will be to: (1) Work with the existing team to lead in the creation of a viable 5 year business plan; (2) Obtain university approval for the venture; (3) a. Act for the company in the spin-out legal process and address all company formation matters; b. Obtain founder academics' and Newcastle University (including the Head of Company Creation) approval for appointment as CEO or agreed post supporting Daniel Peters c. Provide to the appropriate university all matters necessary for Research England reporting requirements; (4) Leading and work alongside the existing team to secure start up funding (venture capital and other) funding Stage (5) will produce the funds by which the new start-up company can consider employing the executive going forward. It is expected, and the intent of the scheme, that the Executive will remain with the business following the end of the contract period. However, such appointment will be at the discretion of the board and appropriate university and will be subject to confirmation, typically at Stage 4 above
Lot Information
Lot 1
Caf1 is secreted from the bacterium Yersinia pestis to protect it from white blood cells during infection. It is formed from 15 kDa monomers that produce robust, flexible polymers up to 2 um in length. We aim to create a spinout company that will initially produce Caf1 polymers and coated plasticware/microcarriers for the 2D cell culture market, predominantly focussed on laboratory research, expanding into commercial companies looking to scale up cell production. The Newcastle-based company will supply these products directly to customers, and through marketing partners who have established distribution networks. We are looking for a CEO/COO/Chairperson to work alongside Daniel Peters to develop a business plan that has considered the best market strategy for Caf1 in preparation for spinout formation and achieving the necessary fundraising The initial brief of the executive will be to: (1) Work with the existing team to lead in the creation of a viable 5 year business plan; (2) Obtain university approval for the venture; (3) a. Act for the company in the spin-out legal process and address all company formation matters; b. Obtain founder academics' and Newcastle University (including the Head of Company Creation) approval for appointment as CEO or agreed post supporting Daniel Peters c. Provide to the appropriate university all matters necessary for Research England reporting requirements; (4) Leading and work alongside the existing team to secure start up funding (venture capital and other) funding Stage (5) will produce the funds by which the new start-up company can consider employing the executive going forward. It is expected, and the intent of the scheme, that the Executive will remain with the business following the end of the contract period. However, such appointment will be at the discretion of the board and appropriate university and will be subject to confirmation, typically at Stage 4 above
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-0334e1
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/011844-2022
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Dynamic
- Procurement Category
- Services
- Procurement Method
- Selective
- Procurement Method Details
- Restricted procedure
- Tender Suitability
- Not specified
- Awardee Scale
- SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
79 - Business services: law, marketing, consulting, recruitment, printing and security
-
- CPV Codes
79400000 - Business and management consultancy and related services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £29,500 Under £100K
Notice Dates
- Publication Date
- 6 May 20223 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 11 Apr 20223 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NEWCASTLE UNIVERSITY
- Additional Buyers
NORTHUMBRIA UNIVERSITY NEWCASTLE
- Contact Name
- Mrs Natalie Morton
- Contact Email
- cheryl.holmstrom@sunderland.ac.uk, david.pratt@tees.ac.uk, edwin.e.milligan@durham.ac.uk, hugh.rhodes@northumbria.ac.uk, natalie.morton@ncl.ac.uk, pb487@bath.ac.uk
- Contact Phone
- +44 1912086396
Buyer Location
- Locality
- NEWCASTLE
- Postcode
- NE1 7RU
- Post Town
- Newcastle upon Tyne
- Country
- England
-
- Major Region (ITL 1)
- TLC North East (England)
- Basic Region (ITL 2)
- TLC4 Northumberland, Durham and Tyne & Wear
- Small Region (ITL 3)
- TLC43 Tyneside
- Delivery Location
- TLC North East (England)
-
- Local Authority
- Newcastle upon Tyne
- Electoral Ward
- Monument
- Westminster Constituency
- Newcastle upon Tyne Central and West
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-0334e1-2022-05-06T13:20:52+01:00",
"date": "2022-05-06T13:20:52+01:00",
"ocid": "ocds-h6vhtk-0334e1",
"initiationType": "tender",
"tender": {
"id": "DN602760",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "(NU/1433-30) CAF1 - A robust, easily engineered polymer with applications in synthetic biology: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "79400000",
"description": "Business and management consultancy and related services"
},
"mainProcurementCategory": "services",
"description": "Caf1 is secreted from the bacterium Yersinia pestis to protect it from white blood cells during infection. It is formed from 15 kDa monomers that produce robust, flexible polymers up to 2 um in length. We aim to create a spinout company that will initially produce Caf1 polymers and coated plasticware/microcarriers for the 2D cell culture market, predominantly focussed on laboratory research, expanding into commercial companies looking to scale up cell production. The Newcastle-based company will supply these products directly to customers, and through marketing partners who have established distribution networks. We are looking for a CEO/COO/Chairperson to work alongside Daniel Peters to develop a business plan that has considered the best market strategy for Caf1 in preparation for spinout formation and achieving the necessary fundraising The initial brief of the executive will be to: (1) Work with the existing team to lead in the creation of a viable 5 year business plan; (2) Obtain university approval for the venture; (3) a. Act for the company in the spin-out legal process and address all company formation matters; b. Obtain founder academics' and Newcastle University (including the Head of Company Creation) approval for appointment as CEO or agreed post supporting Daniel Peters c. Provide to the appropriate university all matters necessary for Research England reporting requirements; (4) Leading and work alongside the existing team to secure start up funding (venture capital and other) funding Stage (5) will produce the funds by which the new start-up company can consider employing the executive going forward. It is expected, and the intent of the scheme, that the Executive will remain with the business following the end of the contract period. However, such appointment will be at the discretion of the board and appropriate university and will be subject to confirmation, typically at Stage 4 above",
"lots": [
{
"id": "1",
"description": "Caf1 is secreted from the bacterium Yersinia pestis to protect it from white blood cells during infection. It is formed from 15 kDa monomers that produce robust, flexible polymers up to 2 um in length. We aim to create a spinout company that will initially produce Caf1 polymers and coated plasticware/microcarriers for the 2D cell culture market, predominantly focussed on laboratory research, expanding into commercial companies looking to scale up cell production. The Newcastle-based company will supply these products directly to customers, and through marketing partners who have established distribution networks. We are looking for a CEO/COO/Chairperson to work alongside Daniel Peters to develop a business plan that has considered the best market strategy for Caf1 in preparation for spinout formation and achieving the necessary fundraising The initial brief of the executive will be to: (1) Work with the existing team to lead in the creation of a viable 5 year business plan; (2) Obtain university approval for the venture; (3) a. Act for the company in the spin-out legal process and address all company formation matters; b. Obtain founder academics' and Newcastle University (including the Head of Company Creation) approval for appointment as CEO or agreed post supporting Daniel Peters c. Provide to the appropriate university all matters necessary for Research England reporting requirements; (4) Leading and work alongside the existing team to secure start up funding (venture capital and other) funding Stage (5) will produce the funds by which the new start-up company can consider employing the executive going forward. It is expected, and the intent of the scheme, that the Executive will remain with the business following the end of the contract period. However, such appointment will be at the discretion of the board and appropriate university and will be subject to confirmation, typically at Stage 4 above",
"awardCriteria": {
"criteria": [
{
"name": "Ability to meet the required programme",
"type": "quality",
"description": "Pass/Fail"
},
{
"name": "Quality: Ability to meet the Job description",
"type": "quality",
"description": "60%"
},
{
"name": "Quality: Ability to meet the Job description",
"type": "quality",
"description": "Pass/Fail"
},
{
"name": "Formal Appointment",
"type": "quality",
"description": "Pass/Fail"
},
{
"type": "price",
"description": "40%"
}
]
},
"hasOptions": false,
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UKC"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "selective",
"procurementMethodDetails": "Restricted procedure",
"techniques": {
"hasDynamicPurchasingSystem": true
},
"reviewDetails": "The University will incorporate a standstill period at the point information on the award of the contract is communicated to tenderers. That notification will provide full information on the award decision. The standstill period, which will be for a minimum of 10 calendar days, provides time for unsuccessful tenderers to challenge the award decision before the contract is entered into. The Public Contracts Regulations 2015 (SI 2015 No 102) provide for aggrieved parties who have been harmed or are at risk of harm by a breach of the rules to take action in the High Court (England, Wales and Northern Ireland) within 30 days of knowledge or constructive knowledge of breach."
},
"awards": [
{
"id": "011844-2022-NU/1433-30-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-52147",
"name": "KWWK Ltd"
}
]
}
],
"parties": [
{
"id": "GB-FTS-168",
"name": "Newcastle University",
"identifier": {
"legalName": "Newcastle University"
},
"address": {
"streetAddress": "Newcastle University, Procurement Services, Kingsgate",
"locality": "Newcastle",
"region": "UKC",
"postalCode": "NE1 7RU",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Mrs Natalie Morton",
"telephone": "+44 1912086396",
"email": "natalie.morton@ncl.ac.uk"
},
"roles": [
"buyer",
"centralPurchasingBody"
],
"details": {
"url": "https://www.ncl.ac.uk",
"buyerProfile": "https://www.ncl.ac.uk",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "09",
"description": "Education"
}
]
}
},
{
"id": "GB-FTS-41290",
"name": "Durham University",
"identifier": {
"legalName": "Durham University"
},
"address": {
"locality": "Stockton Road Durham",
"region": "UKC",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "Edwin.e.milligan@durham.ac.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.durham.ac.uk"
}
},
{
"id": "GB-FTS-38689",
"name": "Northumbria University Newcastle",
"identifier": {
"legalName": "Northumbria University Newcastle"
},
"address": {
"locality": "Newcastle,Tyne and Wear",
"region": "UKC",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "Hugh.Rhodes@northumbria.ac.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.northumbria.ac.uk"
}
},
{
"id": "GB-FTS-171",
"name": "University of Sunderland",
"identifier": {
"legalName": "University of Sunderland"
},
"address": {
"locality": "Sunderland",
"region": "UKC",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "Cheryl.Holmstrom@sunderland.ac.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://sunderland.ac.uk/"
}
},
{
"id": "GB-FTS-38690",
"name": "Teesside University",
"identifier": {
"legalName": "Teesside University"
},
"address": {
"locality": "Middlesbrough, Tees Valley",
"region": "UKC",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "David.Pratt@tees.ac.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.tees.ac.uk/"
}
},
{
"id": "GB-FTS-38691",
"name": "University of Bath on behalf of the SETsquared",
"identifier": {
"legalName": "University of Bath on behalf of the SETsquared"
},
"address": {
"locality": "Claverton Down, Bath",
"region": "UK",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "pb487@bath.ac.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.bath.ac.uk/"
}
},
{
"id": "GB-FTS-172",
"name": "European Union",
"roles": [
"funder"
]
},
{
"id": "GB-FTS-52147",
"name": "KWWK Ltd",
"identifier": {
"legalName": "KWWK Ltd"
},
"address": {
"locality": "Cheshire",
"region": "UK",
"postalCode": "WA1 1RG",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-174",
"name": "Newcastle University",
"identifier": {
"legalName": "Newcastle University"
},
"address": {
"locality": "Tyne and Wear",
"postalCode": "NE1 7RU",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody",
"mediationBody"
]
},
{
"id": "GB-FTS-1062",
"name": "Newcastle University",
"identifier": {
"legalName": "Newcastle University"
},
"address": {
"locality": "Tyne and Wear",
"countryName": "United Kingdom"
},
"roles": [
"reviewContactPoint"
]
}
],
"buyer": {
"id": "GB-FTS-168",
"name": "Newcastle University"
},
"planning": {
"budget": {
"finance": [
{
"id": "1",
"description": "Northern Accelerator programme involving funding from both the European Regional Development Funding (ERDF) and Research England.",
"financingParty": {
"name": "European Union",
"id": "GB-FTS-172"
},
"relatedLots": [
"1"
]
}
]
}
},
"contracts": [
{
"id": "011844-2022-NU/1433-30-1",
"awardID": "011844-2022-NU/1433-30-1",
"status": "active",
"value": {
"amount": 29500,
"currency": "GBP"
},
"dateSigned": "2022-04-12T00:00:00+01:00"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 4
},
{
"id": "2",
"measure": "smeBids",
"relatedLot": "1",
"value": 4
},
{
"id": "3",
"measure": "foreignBidsFromEU",
"relatedLot": "1",
"value": 0
},
{
"id": "4",
"measure": "foreignBidsFromNonEU",
"relatedLot": "1",
"value": 4
},
{
"id": "5",
"measure": "electronicBids",
"relatedLot": "1",
"value": 4
}
]
},
"links": [
{
"rel": "prev",
"href": "https://ted.europa.eu/udl?uri=TED:NOTICE:016574-2019:TEXT:EN:HTML"
}
],
"language": "en"
}